Helaine, C.; Ferré, A.E.; Leblond, M.M.; Pérès, E.A.; Bernaudin, M.; Valable, S.; Petit, E.
Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study. Cancers 2020, 12, 3585.
https://doi.org/10.3390/cancers12123585
AMA Style
Helaine C, Ferré AE, Leblond MM, Pérès EA, Bernaudin M, Valable S, Petit E.
Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study. Cancers. 2020; 12(12):3585.
https://doi.org/10.3390/cancers12123585
Chicago/Turabian Style
Helaine, Charly, Aurélie E. Ferré, Marine M. Leblond, Elodie A. Pérès, Myriam Bernaudin, Samuel Valable, and Edwige Petit.
2020. "Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study" Cancers 12, no. 12: 3585.
https://doi.org/10.3390/cancers12123585
APA Style
Helaine, C., Ferré, A. E., Leblond, M. M., Pérès, E. A., Bernaudin, M., Valable, S., & Petit, E.
(2020). Angiopoietin-2 Combined with Radiochemotherapy Impedes Glioblastoma Recurrence by Acting in an Autocrine and Paracrine Manner: A Preclinical Study. Cancers, 12(12), 3585.
https://doi.org/10.3390/cancers12123585